C12Y 306/04013
Rna helicase
Official title: RNA helicase (3.6.4.13)
C12Y306/04013 (Rna helicase) appears on 24 US grants and 52 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 52
- Assignees
- 56
- Inventors
- 152
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 2 | 4 |
| 2016 | 1 | 4 |
| 2017 | 3 | 4 |
| 2018 | 2 | 4 |
| 2019 | 0 | 3 |
| 2020 | 4 | 4 |
| 2021 | 2 | 6 |
| 2022 | 3 | 1 |
| 2023 | 1 | 5 |
| 2024 | 2 | 6 |
| 2025 | 3 | 3 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors24 Mar 2026US 12,584,174 B2Regeneron Pharmaceuticals, Inc.
- Conserved region T cell vaccines for coronavirus and methods of use22 Jul 2025US 12,364,750 B1Beth Israel Deaconess Medical Center, Inc.
- Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)21 Jan 2025US 12,203,138 B2Board of Regents, The University of Texas System
- System and method for modulating stress granule assembly14 Jan 2025US 12,195,768 B2The Trustees of Princeton University
- Engineered chimeric fusion protein compositions and methods of use thereof9 Jul 2024US 12,030,938 B2Myeloid Therapeutics, Inc.
- Modified helicases1 Oct 2026US 2026/0297544 A1Oxford Nanopore Technologies PLC
- Trigger-inducible mrna circularization23 Jul 2026US 2026/0209789 A1Westlake University
- Improved system for producing rna-packaged aav particles9 Jul 2026US 2026/0193673 A1Huidagene Therapeutics (Singapore) Pte. Ltd.
- Compositions and methods for the immobilization of enzymes using crosslinked biomolecular condensates5 Mar 2026US 2026/0062692 A1Rutgers, The State University of New Jersey
- Composition for prevention or treatment of cancer comprising ddx54 inhibitor and cancer immunotherapy agent3 Jul 2025US 2025/0215434 A1Korea Advanced Institute of Science and Technology
Most cited
By later US patents
- Cells and methods for producing rhamnolipids12US 9,005,928 B2Evonik Degussa GmbH · 2015
- Polynucleotides encoding BREX system polypeptides and methods of using same10US 10,767,156 B2Yeda Research and Development Co. Ltd. · 2020
- Capping prone RNA polymerase enzymes and their applications10US 9,540,671 B2Eukarys · 2017
- Cells and methods for producing rhamnolipids9US 9,580,720 B2Evonik Degussa GmbH · 2017
- Capping-prone RNA polymerase enzymes and their applications7US 8,962,292 B2Eukarys · 2015